(Q34005890)

English

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A prospective epidemiological study of new incident GISTs during two consecutive years in Rhône Alpes region: incidence and molecular distribution of GIST in a European region (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

Isabelle Ray-Coquard

11

object named as

I Ray-Coquard

0 references

10

object named as

J-Y Blay

0 references

author name string

P A Cassier

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

F Ducimetière

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A Lurkin

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D Ranchère-Vince

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

J-Y Scoazec

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P-P Bringuier

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

A-V Decouvelaere

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

P Méeus

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

D Cellier

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

0 references

publication date

29 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

British Journal of Cancer

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

103

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

165-170

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Epidemiological evaluation of concordance between initial diagnosis and central pathology review in a comprehensive and prospective series of sarcoma patients in the Rhone-Alpes region

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Correlation of kinase genotype and clinical outcome in the North American Intergroup Phase III Trial of imatinib mesylate for treatment of advanced gastrointestinal stromal tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Minute gastric sclerosing stromal tumors (GIST tumorlets) are common in adults and frequently show c-KIT mutations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Gastrointestinal stromal tumors: pathology and prognosis at different sites

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

PDGFRA mutations in gastrointestinal stromal tumors: frequency, spectrum and in vitro sensitivity to imatinib

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

A great majority of GISTs with PDGFRA mutations represent gastric tumors of low or no malignant potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

PDGFRA activating mutations in gastrointestinal stromal tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2906738

5 July 2018

Tumor mitotic rate, size, and location independently predict recurrence after resection of primary gastrointestinal stromal tumor (GIST).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605743

21 January 2018

Incidence of gastrointestinal stromal tumours is underestimated: results of a nation-wide study.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605743

21 January 2018

Adjuvant treatment of GIST with imatinib: solid ground or still quicksand? A comment on behalf of the EORTC Soft Tissue and Bone Sarcoma Group, the Italian Sarcoma Group, the NCRI Sarcoma Clinical Studies Group (UK), the Japanese Study Group on GIST

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605743

21 January 2018

High incidence of microscopic gastrointestinal stromal tumors in the stomach.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605743

21 January 2018

Deletions affecting codons 557-558 of the c-KIT gene indicate a poor prognosis in patients with completely resected gastrointestinal stromal tumors: a study by the Spanish Group for Sarcoma Research (GEIS).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605743

21 January 2018

Gastrointestinal stromal tumors: the incidence, prevalence, clinical course, and prognostication in the preimatinib mesylate era--a population-based study in western Sweden

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BJC.6605743

21 January 2018

The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST)

1 reference

https://pubmed.ncbi.nlm.nih.gov/20588273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Diagnosis of gastrointestinal stromal tumors: A consensus approach

1 reference

https://pubmed.ncbi.nlm.nih.gov/20588273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

KIT and PDGFRalpha mutations in 104 patients with gastrointestinal stromal tumors (GISTs): a population-based study

1 reference

https://pubmed.ncbi.nlm.nih.gov/20588273

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1038/SJ.BJC.6605743

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34005890&oldid=2196107261"